A writ petition was filed before the Delhi High Court by I-MAK and DNP+, challenging the grant of patent to costly Hepatitis-C drug, Sofosbuvir. The first hearing for the case was expected take place on 13th September. However, the hearing has been adjourned. Patent Controller and Union of India asked for postponement of the case as they needed more time to submit their response to the petition. The patent was granted to Gilead for this drug in May 2016.
The judge has given a week’s time to make the submission. However, next date given for hearing is now for 22nd November.
Read I-MAK/DNP+ press release issued in July
MSF Press release issued on grant of patent